Ether/Acetal Active Ingredients TRIZ Cases

A 2:1 NR and pterostilbene composition raises NAD+ and lowers nitric oxide in chondrocytes to slow osteoarthritis progression.

Blocking RT-driven lipid metabolism with a FASN inhibitor helps PD-1 therapy overcome glioblastoma immunosuppression and resistance.

A glyceryl ether-phospholipid composition forms a water-triggered film that stays on mucosa and skin longer to protect inflamed tissue.

A multi-herb analgesic composition combines complementary pathways to relieve pain while reducing opioid use and withdrawal symptoms.

A segmented oral formulation combines guaifenesin, naproxen, and dextromethorphan to balance rapid onset with up to 12-hour relief.

Pre-phosphorylated sulfur-containing nucleosides use prodrug moieties to improve cellular uptake and intracellular activation against RNA viruses.

Substituted anticancer compounds inhibit cancer cell proliferation and induce apoptosis, including in cancer stem cells.

A polymeric solubilizing matrix dissolves analgesics in softgel fill compositions to maintain clear liquid states.

A tablet formulation uses carnauba wax as a primary base material combined with edible oils and natural excipients to create stable drug delivery systems.

Systematically modifying structural parameters of benzyloxy ethers to resolve the contradiction between development time and therapeutic efficacy.

Administering pterostilbene before glutathione depletion overcomes short half-life limitations to improve anticancer efficacy.

TH receptor antagonists block thyroid hormone signaling to increase cone density and reduce degeneration, despite disrupting dorsal-ventral opsin patterning.

Seviteronel and dexamethasone compositions balance enzyme inhibition potency and selectivity by tailoring metal-binding groups to active site geometry.

A clear aerosol sealant coats metal surfaces with a resin barrier to prevent skin irritation and tarnishing.

Polyethylene glycol and povidone stabilize the suspension to prevent phase separation, enabling smaller capsule sizes without compromising therapeutic efficacy.

A nutraceutical blend of EGCG, pterostilbene, and sulforaphane stimulates natural killer cells to combat viral infections.

A therapeutic composition of dried cranberry powder and seed meal reduces LUTS severity while avoiding synthetic drug side effects.

A combination medication merges decongestant, antihistamine, and antitussive agents into a single dosage form.

A pharmaceutical composition of Crassulaceae, Araliaceae, and Schisandraceae extracts regulates cholesterol, triglyceride, albumin, and protein concentrations.

Fusing autologous dendritic cells with tumor cells overcomes limited immune responses by directly presenting antigens to activate robust T cell elimination.

DMPBD inhibits cell adhesion molecules to prevent cancer metastasis while reducing toxicity.

A ZIP9 inhibitor targets nonclassical androgen receptors to reduce tumor proliferation in male patients.

Tetra-O-methyl nordihydroguaiaretic acid inhibits BNIP3 expression to reduce necrosis and apoptosis during ischemia reperfusion injury.

A polymer-drug conjugate with cleavable linkers enables selective drug release at tumor sites.

Segmenting a capsule into separate compartments allows precise control over active ingredient release profiles while simplifying the manufacturing process.

Iso-garcinol and octahydrocurcumin lower HIF-1α, TGF-β, IL-13, TNF-α, and MUC5B to alleviate hypoxia and inflammation in pulmonary fibrosis.

Oral nicotinamide riboside and pterostilbene compositions treat ischemia and drug-induced toxicity by enhancing kidney function and blood flow.

A nutraceutical composition combining broccoli, green tea, and pterostilbene increases natural killer cell cytotoxicity.

Compounds inhibit the anaphase promoting complex to induce mitotic arrest in cancer cells.

Anhydrous alcohol scavenges water migrating from the shell, preventing API degradation while maintaining structural integrity.

Pterostilbene mitigates age-related ovarian decline by suppressing cellular deterioration and enhancing egg quality.

Liposomal encapsulation with alpha lipoic acid prevents ubiquinol oxidation, maintaining bioavailability despite low hydrophilic solubility.

Reconstituted apolipoprotein B lipoparticles transport hydrophobic cargo via LDL receptor-mediated endocytosis, resolving physiological solubility barriers.

A matrix tablet uses a non-ionic oxyl-containing hydrophilic polymer to control the release rate of tri-oxy active agents.

Mesenchymal stem cell apoptotic bodies modulate inflammatory responses to mitigate cognitive decline.

Selective TEAD inhibitors block YAP TAZ binding to downregulate oncogenic transcription and inhibit tumor growth.

A resveratrol analog induces apoptosis in resistant lung cancer cells.